HB Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,000
Closed -$7.03M 774
2023
Q2
$7.03M Buy
+15,000
New +$6.29M 0.11% 97

Other funds holding LLY

HB Wealth Management's LLY Position: Q1 2026 in Review

HB Wealth Management increased its Eli Lilly (LLY) stake by 6.6% in Q1 2026, buying an estimated $3.96M and bringing the position to 63,028 shares worth $58M. The position accounts for 0.38% of the portfolio, ranked #39.

HB Wealth Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $63.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • HB Wealth Management held 63,028 shares of Eli Lilly worth $58M as of Q1 2026.
  • HB Wealth Management bought 3,907 Eli Lilly shares in Q1 2026, an estimated $3.96M.
  • Eli Lilly made up 0.38% of HB Wealth Management's portfolio in Q1 2026, its #39 holding.
  • HB Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • HB Wealth Management's Eli Lilly position peaked at $63.5M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on HB Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.